Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.E A Neuwelt, Bruce W. Dana, J Crossen et al.|Journal of Clinical Oncology|1991Cited by 383
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.Bruce W. Dana, R I Fisher, Thomas P. Miller et al.|Journal of Clinical Oncology|1993Cited by 193
Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective seriesEdward A. Neuwelt, Suellen A. Hill, Bruce W. Dana et al.|Cancer|1986Cited by 123
Toxicity and Efficacy of Carboplatin and Etoposide in Conjunction with Disruption of the Blood-Brain Tumor Barrier in the Treatment of Intracranial NeoplasmsPaul C. Williams, Edward A. Neuwelt, Suellen A. Dahlborg et al.|Neurosurgery|1995Cited by 108
Interferon Alfa Consolidation After Intensive Chemotherapy Does Not Prolong the Progression-Free Survival of Patients With Low-Grade Non-Hodgkin’s Lymphoma: Results of the Southwest Oncology Group Randomized Phase III Study 8809Richard I. Fisher, Thomas P. Miller, Bruce W. Dana et al.|Journal of Clinical Oncology|2000Cited by 81